Leaflet TAPTIQOM 15mcg / 5mg / ml eye drops, solution in single-dose vial
Indicated for: glaucoma; ocular hypertension
Route of administration: ophthalmic
Substance: tafluprost + timolol (glaucoma agent + beta blocker)
ATC: S01ED51 (Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents)
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Older people may have an increased risk of side effects.
This combination of tafluprost and timolol is used for the treatment of open-angle glaucoma and ocular hypertension. Tafluprost lowers intraocular pressure by increasing the outflow of aqueous humor, while timolol reduces the production of aqueous humor.
The medication is administered as eye drops, usually once daily, as directed by a doctor. It is important for patients to follow the usage instructions to achieve maximum efficacy.
Patients should be aware of potential side effects, such as eye irritation, redness, or a sensation of dryness in the eyes. It is important to inform the doctor of any unusual symptoms.
Common side effects include eye irritation, a burning or itching sensation, and gradual changes in iris color. In rare cases, allergic reactions, ocular inflammation, or a decrease in heart rate may occur. Patients should be informed of these risks before starting treatment.
General data about TAPTIQOM 15mcg / 5mg / ml
- Substance: tafluprost + timolol
- Date of latest medicines list: 01-07-2015
- Product code: W61386001
- Concentration: 15mcg / 5mg / ml
- Pharmaceutical form: eye drops, solution in single-dose vial
- Quantity: 30
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.